iBio, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementCommon Stock • July 3rd, 2024 • iBio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 3rd, 2024 Company Industry JurisdictioniBio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Chardan Capital Markets, LLC (“Chardan”) and Craig-Hallum Capital Group LLC (“Craig-Hallum”), each as sales agent (each an “Agent” and together, the “Agents”) as follows: